CTOR
Citius Oncology, Inc.
1.10$
+4.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | 20.0% | 19.7% | 148.1% | – | |
| – | – | – | – | – | – | – | – | – | 80.0% | 80.3% | -48.1% | – | |
| – | – | – | – | – | – | – | – | – | 25.8% | 64.7% | 14.6% | 47.7% | |
| – | – | – | – | – | – | – | – | – | 172.8% | 1,628.5% | 520.8% | 638.7% | |
| – | – | – | – | – | – | – | – | – | 213.2% | 1,796.4% | 535.4% | 718.8% | |
| – | – | – | – | – | – | – | – | – | -133.2% | -1,716.2% | -583.5% | -665.6% | |
| – | – | – | – | – | – | – | – | – | 1.2% | 2.0% | 27.5% | 7.7% | |
| – | – | – | – | – | – | – | – | – | -133.6% | -1,609.8% | -604.6% | -645.6% | |
| – | – | – | – | – | – | – | – | – | 6.7% | -13.9% | -7.2% | 2.7% | |
| – | – | – | – | – | – | – | – | – | -140.3% | -1,596.0% | -597.4% | -648.3% | |
| – | – | – | – | – | – | – | – | – | -117.9% | -1,607.9% | -468.4% | -607.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.